A new paradigm of cancer immunotherapy based on [18F]FDG and anti-PD-L1 mAb combination

被引：0
|
作者：
Wen, Xuejun [1 ]
Chen, Xiaoyuan [1 ]
Zhang, Xianzhong [1 ]
Guo, Zhide [1 ]
机构：
[1] Xiamen Univ, Xiamen, Peoples R China
来源：
NUCLEAR MEDICINE AND BIOLOGY | 2022年 / 108卷
基金：
中国国家自然科学基金;
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P-312
引用
收藏
页码：S219 / S220
页数：2
相关论文
共 50 条
  • [21] Modulating the tumor microenvironment improves antitumor effect of anti-PD-L1 mAb in breast cancer
    Li, Xiuying
    Luo, Xianqin
    Hu, Shunqin
    BIOIMPACTS, 2023, 13 (02) : 89 - 96
  • [22] Hair RepigmentationWith Anti-PD-1 and Anti-PD-L1 Immunotherapy: A Novel Hypothesis
    Sebaratnam, Deshan Frank
    Rodriguez Bandera, Ana Isabel
    Lowe, Patricia Margaret
    JAMA DERMATOLOGY, 2018, 154 (01) : 112 - 113
  • [23] Which is the optimal immunotherapy for advanced squamous non-small-cell lung cancer in combination with chemotherapy: anti-PD-1 or anti-PD-L1?
    Zhang, Yaxiong
    Zhou, Huaqiang
    Zhang, Li
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [24] Evaluation of [18F]FDG uptake after anti PD-1 therapy in mice
    Tomita, Mayu
    Yasui, Hironobu
    Higashikawa, Kei
    Nakajima, Kohei
    Takakura, Hideo
    Shiga, Tohru
    Kuge, Yuji
    Ogawa, Mikako
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [25] Evaluation of [18F]FDG uptake after anti PD-1 therapy in mice
    Ogawa, M.
    Tomita, M.
    Yasui, H.
    Higashikawa, K.
    Nakajima, K.
    Shiga, T.
    Kuge, Y.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S190 - S191
  • [26] Combination of lipopolysaccharide and polygalacturonic acid exerts antitumor activity and augments anti-PD-L1 immunotherapy
    Song, Jie
    Li, Jiaxin
    Zhang, Anping
    Tan, Xiaobin
    Li, Sujuan
    Luo, Lixia
    Wang, Sen
    Wei, Guoli
    Zhang, Zhenhai
    Huo, Jiege
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 281
  • [27] Sulindac Modulates the Response of Proficient MMR Colorectal Cancer to Anti-PD-L1 Immunotherapy
    Yi, Bin
    Cheng, Hao
    Wyczechowska, Dorota
    Yu, Qingzhao
    Li Li
    Ochoa, Augusto C.
    Riker, Adam, I
    Xi, Yaguang
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (07) : 1295 - 1304
  • [28] Sulindac modulates the response of triple negative breast cancer to anti-PD-L1 immunotherapy
    Yi, Bin
    Ma, Ruixia
    Xi, Yaguang
    CANCER RESEARCH, 2024, 84 (06)
  • [29] Discovery of low-molecular weight anti-PD-L1 peptides for cancer immunotherapy
    Liu, Hao
    Zhao, Zhen
    Zhang, Li
    Li, Yuanke
    Jain, Akshay
    Barve, Ashutosh
    Jin, Wei
    Liu, Yanli
    Fetse, John
    Cheng, Kun
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01):
  • [30] Prevotellaceae Modulates Colorectal Cancer Immune Microenvironment to Assist Anti-PD-L1 Immunotherapy
    Xu, Song
    Kong, Jianqiao
    Dai, Yang
    Li, Hengping
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2024, 35 (12):
12345